Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells. [PDF]
Lee SK +4 more
europepmc +1 more source
Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report. [PDF]
Takeno A +3 more
europepmc +1 more source
Effect of breastfeeding on serum osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in full term neonates. [PDF]
Rafeey M +4 more
europepmc +1 more source
Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health. [PDF]
Tabari ZA +4 more
europepmc +1 more source
RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis. [PDF]
O'Brien W +7 more
europepmc +1 more source
8-Epixanthatin Suppresses RANKL-Induced Osteoclast Differentiation via Inhibition of NF-κB and MAPK Signaling. [PDF]
Zhang L, Deepak V.
europepmc +1 more source

